Priority Date: 18.11.11 (US 201161632813P)

MUSCARINIC M1 RECEPTOR AGONISTS

  • Application ID: EP12794751
  • Status: PATENT GRANTED

Attorney

Company dna stratagem ipm limited
no operation time available
3 offices
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Stratagem IPM Limited is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 18.11.2011 - Priority Date (US 201161632813P)
  • 23.05.2013 - Publication A1 (WO2013072705)
  • 24.09.2014 - Publication A1 (EP2780015)
  • 04.01.2017 - Publication B1 (EP2780015)